Although these findings suggest that CD70 has tumor suppressor capability, it has also been implied to play an oncogenic role based on the inferior prognosis of patients with DLBCL, exhibiting high CD70 expression [35]. This evidence concerns the gene CD70 and diffuse large B-cell lymphoma.